Learn how the FDA's 180-day exclusivity works for generic drug applicants, including Paragraph IV certifications, forfeiture risks, and upcoming regulatory changes.
Sep, 11 2025
Jun, 19 2026
May, 23 2025
Jul, 30 2026
Apr, 16 2026